Evidence map›Paper›PMID 23732511›Full record

ArticleNeurotoxicology2013

Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Marco Vinceti, Nikolay Solovyev, Jessica Mandrioli, Catherine M Crespi, Francesca Bonvicini, Elisa Arcolin, Eleni Georgoulopoulou, Bernhard Michalke

Open access · hybridAbstract read
In one paragraph

Article in Neurotoxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 5 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 5 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Pooled it
  5. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2014
    Pooled it
  6. Article
  7. Review
  8. Article
  9. Article
  10. Effects and Impact of Selenium on Human Health, A Review.Molecules (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Metals in ALS TDP-43 Pathology.International journal of molecular sciences · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Marco VincetiCREAGEN - Environmental, Genetic and Nutritional Epidemiology Research Center, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: marco.vinceti@unimore.it.
Nikolay Solovyev
Jessica Mandrioli
Catherine M Crespi
Francesca Bonvicini
Elisa Arcolin
Eleni Georgoulopoulou
Bernhard Michalke
University of Modena and Reggio Emilia · ITHelmholtz Zentrum München · DEUniversity of California, Los Angeles · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124
6 · The paper itself

Abstract

Exposure to selenium, and particularly to its inorganic forms, has been hypothesized as a risk factor for amyotrophic lateral sclerosis (ALS), a fast progressing motor neuron disease with poorly understood etiology. However, no information is known about levels of inorganic and some organic selenium species in the central nervous system of ALS patients, and recent observations suggest that peripheral biomarkers of exposure are unable to predict these levels for several Se species including the inorganic forms. Using a hospital-referred case-control series and advanced selenium speciation methods, we compared the chemical species of selenium in cerebrospinal fluid from 38 ALS patients to those of 38 reference neurological patients matched on age and gender. We found that higher concentrations of inorganic selenium in the form of selenite and of human serum albumin-bound selenium were associated with increased ALS risk (relative risks 3.9 (95% confidence interval 1.2-11.0) and 1.7 (1.0-2.9) for 0.1μg/L increase). Conversely, lower concentrations of selenoprotein P-bound selenium were associated with increased risk (relative risk 0.2 for 1μg/L increase, 95% confidence interval 0.04-0.8). The associations were stronger among cases age 50 years or older, who are postulated to have lower rates of genetic disease origin. These results suggest that excess selenite and human serum albumin bound-selenium and low levels of selenoprotein P-bound selenium in the central nervous system, which may be related, may play a role in ALS etiology.

Indexed as

AdultAgedAge FactorsAmyotrophic Lateral SclerosisCase-Control StudiesFemaleHumansMaleMiddle AgedRisk FactorsSelenious AcidSelenium CompoundsSelenoprotein PSelenious AcidSelenium CompoundsSelenoprotein PAmyotrophic lateral sclerosisCase–control studyCerebrospinal fluidEnvironmentRiskSeleniteSeleniumSelenoprotein-PSpeciation analysis

Identifiers

PMID23732511
PMCPMC3770807
OpenAlexW2015075565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.